The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with ...

Understanding the rate of erectile dysfunction (ED) and testosterone deficiency is crucial in developing screening and ...

For patients undergoing breast reconstruction after mastectomy, age impacts surgical outcomes, with older age negatively ...

Vaccination is one of the most effective ways to protect children against influenza and its complications, including severe ...

Exposure to extreme heat stress is associated with increased risks for emergency department visits and unplanned hospital ...

Separate studies investigated the potential role of multiparametric MRI in refining prostate cancer active surveillance ...

The investigators defined hyponatremia as a serum sodium level less than 135 mEq/L, and mild, moderate, and severe ...

A high omega-3, low omega-6 diet with fish oil supplementation for 1 year results in a significant reduction of a marker of ...

Compared with women with normotensive pregnancies, women with gestational hypertension, preeclampsia, and eclampsia all had ...

Donor-derived cell free DNA shows promise for identifying subclinical antibody-mediated rejection in kidney transplant ...

Investigators report improvement in cognitive construct scores among individuals who consumed more than 5 cups of coffee/day ...